BIIB

Biogen
D

BIIB

Arincen57/100B

Biogen executives and insider trading

Christopher A. Viehbacher reported no open-market purchases or sales over the last twelve months.

Over the last twelve months Biogen's insiders sold 4,594 shares for 905,414 USD in 4 sales on the open market, and bought 3 shares in 1 purchases.

Insiders over the last twelve months

Insider sales
4
Shares sold
4,594
Value sold
905.41K USD
Insider purchases
1

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
0
0
6 months
239.75K USD
585.11 USD
1 year
905.41K USD
152.14K USD
2 years
3.09M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Priya Singhal Executive Vice President & Head of Development583,408665.66K USD—9 Feb 20268,043
Lloyd Minor Director—1,186239.75K USD—4 Aug 20262,689
Nicole Murphy Executive Vice President and Head of Pharmaceutical Operations & Technology53——3—19,611

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
4 Aug 2026Lloyd MinorSale593200.96119.17K USD2,689Form 4
3 Aug 2026Lloyd MinorSale593203.34120.58K USD3,282Form 4
12 Feb 2026Nicole MurphyPurchase3195.04585.11 USD19,611Form 4
9 Feb 2026Priya SinghalSale2,660199.83531.55K USD8,043Form 4
2 Feb 2026Priya SinghalSale748179.30134.12K USD6,271Form 4
2 Sept 2025Priya SinghalSale517133.5569.05K USD5,772Form 4
8 Jul 2025Rachid IzzarSale2,223135.00300.11K USD6,330Form 4
19 May 2025Priya SinghalSale3,806126.25480.51K USD5,427Form 4
2 May 2025Caroline DorsaPurchase1,235122.72151.56K USD27,842Form 4
7 Mar 2025Stephen A SherwinSale8,760150.021.31M USD11,318Form 4
9 Dec 2024Priya SinghalSale110157.2117.29K USD5,426Form 4

Common questions about Biogen's executives and insiders

Source: Financial Modeling Prep